ID 原文 译文
1217 2.3输注方案 通常给与1次输注量≥400mL，或予多次每次≥200mL的恢复期血浆治疗。 2.3 Infusion plan in general, the dosage of convalescent plasma therapy is ≥400 mL for one infusion, or ≥ 200 mL per infusion for multiple infusions.
1218 十二. 中医分型治疗提高疗效 XII. TCM Classification Therapy to Improve Curative Efficacy
1219 分型分期 Classification and Stage
1220 COVID-19可分为初期、中期、重症期及恢复期。 COVID-19 can be divided into early, middle, critical and recover y stages.
1221 初期以寒湿郁肺和外寒内热两型为主；中期以寒热错杂为先；重症期为疫毒内闭多见；恢复期重在肺脾气虚。 At the early stage, the disease has two main types: “wet lungs” and “external cold and internal heat.” The middle stage is characterized by “intermit tent cold and heat.” The critical stage is characterized by “internal block of epidemic toxin.” The recovery stage is characterized by “qi deficiency in lung-spleen.”
1222 该病初期为寒湿证，因兼有发热，可以寒热并用。 The disease initially belongs to wet lung syndrome. Due to fever, both intermit tent cold and heat treatment s are recommended.
1223 中期寒湿热兼见，中医属寒热错杂，故寒热并用，调其升降。 In the middle stage, cold, dampness, and heat coexist, belonging to “cold-heat mixture” in terms of TCM. Both cold and heat therapy should be considered.
1224 中医之治则“热者寒之”，治热以寒，但寒药易伤阳，导致脾胃虚寒，出现中焦寒热错杂之象，也需寒热并用。 According to the theory of TCM, heat should be treated with cold drugs. But cold drugs impair Yang and lead to a cold spleen and stomach and cold-heat mixture in the middle-Jiao.
1225 该病寒热错杂证常见，采用寒热并用法取得了优于其他疗法的效果。 Therefore, in this stage both cold and heat therapies should be considered. Because cold-heat symptoms are commonly seen in COVID-19 patients, the cold-heat therapy is better than other approaches.
1226 分型论治 Therapy Based on Classification